Formation of simvastatin nanoparticles from microemulsion

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 5, Issue 3, 2009, Pages 274-281

  Margulis Goshen, Katy ^a   Magdassi, Shlomo ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Evaporation; Microemulsion; Organic nanoparticles; Poorly soluble drug; Simvastatin

Indexed keywords

AMORPHOUS PARTICLES; CRYSTALLIZATION PROCESS; DISSOLUTION PROFILES; M-FILTERS; OIL PHASE; OIL-IN-WATER MICROEMULSIONS; ORGANIC NANOPARTICLES; POORLY SOLUBLE DRUG; POORLY WATER-SOLUBLE DRUGS; ROOM TEMPERATURE; SIMVASTATIN; VOLATILE SOLVENTS; X- RAY DIFFRACTION;

DEWATERING; DISSOLUTION; EVAPORATION; LOW TEMPERATURE DRYING; MICROCRYSTALS; NANOPARTICLES; SOLVENTS; VAPORS;

MICROEMULSIONS;

NANOPARTICLE; OIL; SIMVASTATIN; SOLVENT; WATER;

ARTICLE; CRYSTALLIZATION; DISSOLUTION; DRUG METABOLISM; DRUG SOLUBILITY; EVAPORATION; FILTRATION; FREEZE DRYING; METHODOLOGY; MICROEMULSION; ROOM TEMPERATURE; STORAGE; X RAY DIFFRACTION;

CRYOELECTRON MICROSCOPY; CRYSTALLIZATION; ELECTRIC CONDUCTIVITY; EMULSIONS; FREEZE DRYING; NANOPARTICLES; PARTICLE SIZE; SIMVASTATIN; SOLUBILITY; TEMPERATURE; X-RAY DIFFRACTION;

EID: 69249236865     PISSN: 15499634     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nano.2008.11.004     Document Type: Article

References (28)

1. Bushrab F.N., and Muller R.H. Nanocrystals of poorly soluble drugs for oral administration. New Drugs Online. 5 (2003) 20-22
2. Noyes A.A., and Whitney W.R. The rate of solution of solid substances in their own solutions. J Am Chem Soc. 19 (1897) 930-934
3. Das N.G., and Das S.K. Formulation of poorly soluble drugs. Drug Deliv Rep (2006) Spring/Summer:52-5
4. Merisko-Liversidge E., Liversidge G.G., and Cooper E.R. Nanosizing: a formulation approach for poorly-water-soluble compounds. Eur J Pharm Sci. 18 (2003) 113-120
5. Matteucci M.E., Brettman B.K., Rogers R.L., Elder E.J., Williams III R.O., and Johnston K.P. Design of potent amorphous drug nanoparticles for rapid generation of highly supersaturated media. Mol Pharm. 4 (2007) 782-793
6. Chen J.F., Zhang J.Y., Shen Z.G., Zhong J., and Yun J. Preparation and characterization of amorphous Cefuroxime Axetil drug nanoparticles with novel technology: high-gravity antisolvent precipitation. Ind Eng Chem Res. 45 (2006) 8723-8727
7. Matteucci M.E. Drug nanoparticles by antisolvent precipitation: mixing energy versus surfactant stabilization. Langmuir. 22 (2006) 8951-8959
8. Rogers T.L., Gillespie I.B., Hitt J.E., Fransen K.L., Crowl C.A., Tucker C.J., et al. Development and characterization of a scalable controlled precipitation process to enhance the dissolution of poorly water-soluble drugs. Pharm Res. 21 (2004) 2048-2057
9. Chen X., Young T.J., Sarkari M., Williams R.O., and Johnston K.P. Preparation of cyclosporine A nanoparticles by evaporative precipitation into aqueous solution. Int J Pharm. 242 (2002) 3-14
10. Türk M., Hils P., Helfgen B., Schaber K., Martin H.J., and Wahl M.A. Micronization of pharmaceutical substances by the rapid expansion of supercritical solutions (RESS): a promising method to improve bioavailability of poorly soluble pharmaceutical agents. J Supercritical Fluids 22 (2002) 75-84
11. Perrut M., Jung J., and Leboeuf F. Enhancement of dissolution rate of poorly-soluble active ingredients by supercritical fluid processes Part I: Micronization of neat particles. Int J Pharm. 288 (2005) 3-10
12. Hu J., Johnson K.P., and Williams R.O. Rapid dissolving high potency danazol powders produced by spray freezing into liquid process. Int J Pharm. 271 (2004) 145-154
13. Kamishny A., and Magdassi S. Nanoparticles in confined structures: formation and application. In: Tadros T.H. (Ed). Colloid stability: the role of surface forces, Part 1 (2007), Wiley-VCH, Weinheim 207-234
14. Desgouilles S., Vauthier C., Bazile D., Vacus J., Grossiord J.L., Veillard M., et al. The design of nanoparticles obtained by solvent evaporation: a comprehensive study. Langmuir. 19 (2003) 9504-9510
15. Shekunov B.Y., Chattopadhyay P., Seitzinger J., and Huff R. Nanoparticles of poorly water-soluble drugs prepared by supercritical fluid extraction of emulsions. Pharm Res. 23 (2006) 196-204
16. Magdassi S, Nativi H, Margulis-Goshen K. Organic nanoparticles obtained from microemulsions by solvent evaporation. International Patent Application No.: PCT/IL2007/001136.
17. Debuigne F., Jeunieau L., Wiame M., and Nagy J.B. Synthesis of organic nanoparticles in different w/o microemulsions. Langmuir. 16 (2000) 7605-7611
18. Destrée C., Ghijsen J., and Nagy J.B. Preparation of organic nanoparticles using microemulsions: their potential use in transdermal delivery. Langmuir. 23 (2007) 1965-1973
19. Destrée C., and Nagy J.B. Mechanism of formation of inorganic and organic nanoparticles from microemulsions. Adv Colloid Interface Sci 123-126 (2006) 353-367
20. Trotta M., Gallarate M., Carlotti M.E., and Morel S. Preparation of griseofulvin nanoparticles from water-dilutable microemulsions. Int J Pharm. 254 (2003) 235-242
21. Carlucci G., Mazzeo P., Biordi L., and Bologna M. Simultaneous determination of simvastatin and its hydroxy acid form in human plasma by high-performance liquid chromatography with UV detection. J Pharm Biomed Anal. 10 (1992) 693-697
22. O'Neil M.J. The Merck index-an encyclopedia of chemicals, drugs and biologicals. 14th ed. (2006), Merck & Co., Inc., Whitehouse Station, NJ 1471-1472
23. Patel R.P., and Patel M.M. Inclusion complexion-physico-chemical characterization and in vitro dissolution behavior of simvastatin-cyclodextrin inclusion compounds. Drug Deliv Technol. 7 (2007) 50-56
24. Pflaum A, Salobir M, Jerala Z, Resman A. Solid pharmaceutical formulation containing lovastatin and simvastatin respectively, and its preparation. United States patent US 6984399.
25. Kang B.K., Lee J.S., Chon S.K.L., Jeong S.Y., Yuk S.H., Khang G., et al. Development of self-microemulsifying drug delivery systems (SMEDDs) for oral bioavailability enhancement of simvastatin in beagle dogs. Int J Pharm. 274 (2004) 65-73
26. Ambike A.A., Mahadik K.R., and Paradkar A. Spray-dried amorphous solid dispersions of simvastatin, a low Tg drug, in vitro and in vivo evaluations. Pharm Res. 22 (2005) 990-998
27. Yang D.J., and Hwang L.S. Study on the conversion of three natural statins from lactone forms to their corresponding hydroxy acid forms and their determination in Pu-Erh tea. J Chromatogr A. 1119 (2006) 277-284
28. Álvarez-Lueje A., Valenzuela C., Squella J.A., and Núńez-Vergara L.J. Stability study of simvastatin under hydrolytic conditions assessed by liquid chromatography. J AOAC Int 88 (2005) 1631-1636